🟢 Moderna is trading 5% up today after positive Phase 3 melanoma results

Moderna is trading 5% up at $181.61 after Moderna and Merck announced positive Phase 3 melanoma results.

• The rally extends Moderna’s 12.27% gain on September 21; detailed intismeran autogene data were selected for ESMO’s Presidential Symposium on October 24.
• Investors are positioning ahead of additional pipeline updates expected on September 23.
• The Nasdaq Composite is up 0.44%, making the move primarily company-specific; trading remains active during the September 22 session, though volume data were unavailable.